Search Within

Weinberg Fellows

  1. "Massachusetts Medical Society"
Formats
  1. Journal Article (7)
  2. Correspondence (1)
  3. Editorial (1)
Groups
  1. Hematology-Oncology Fellows (9)
  2. Department of Medicine (8)
  3. Solid Tumor Oncology Division (6)
  4. GME, Medicine (3)
  5. GSK Faculty (3)
  6. Graduate Medical Education (3)

More Groups

People
  1. Kathryn Arbour (2)
  2. Alexander Drilon (1)
  3. Alexander Penson (1)
  4. Ana Alarcon Tomas (1)
  5. Andrea Cercek Hanjis (1)
  6. Andrew Zelenetz (1)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (1)
  5. 2020 (2)
  6. 2018 (1)
Publications
  1. New England Journal of Medicine (9)
Publishers
  1. Massachusetts Medical Society (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Epigenetic therapy in a rare ovarian cancer - A double-edged sword
    Correspondence

    Hsu, C.; Konner, J. A.; Gounder, M. M.
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save
  • Single-agent Divarasib (GDC-6036) in solid tumors with a KRAS G12C mutation
    Journal Article

    Sacher, A.; LoRusso, P.; Patel, M. R.; Miller, W. H.; Garralda, E.; Forster, M. D.; Santoro, A.; Falcon, A.; Kim, T. W.; Paz-Ares, L.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Noncompete agreements - The need for a refresh
    Editorial

    Mullangi, S.; Agrawal, M.; Richman, B.
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • PD-1 blockade in mismatch repair-deficient, locally advanced rectal cancer
    Journal Article

    Cercek, A.; Lumish, M.; Sinopoli, J.; Weiss, J.; Shia, J.; Lamendola-Essel, M.; El Dika, I. H.; Segal, N.; Shcherba, M.; Sugarman, R.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Mechanisms of resistance to noncovalent Bruton's tyrosine kinase inhibitors
    Journal Article

    Wang, E.; Mi, X.; Thompson, M. C.; Montoya, S.; Notti, R. Q.; Afaghani, J.; Durham, B. H.; Penson, A.; Witkowski, M. T.; Lu, S. X.; more...
    New England Journal of Medicine (2022)

    Fulltext@MSK | Save
  • Acquired resistance to KRAS(G12C) inhibition in cancer
    Journal Article

    Awad, M. M.; Liu, S.; Rybkin, I. I.; Arbour, K. C.; Dilly, J.; Zhu, V. W.; Johnson, M. L.; Heist, R. S.; Patil, T.; Riely, G. J.; more...
    New England Journal of Medicine (2021)

    Fulltext@MSK | Save
  • Efficacy of selpercatinib in RET fusion-positive non-small-cell lung cancer
    Journal Article

    Drilon, A.; Oxnard, G. R.; Tan, D. S. W.; Loong, H. H. F.; Johnson, M.; Gainor, J.; McCoach, C. E.; Gautschi, O.; Besse, B.; Cho, B. C.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation
    Journal Article

    Peled, J. U.; Gomes, A. L. C.; Devlin, S. M.; Littmann, E. R.; Taur, Y.; Sung, A. D.; Weber, D.; Hashimoto, D.; Slingerland, A. E.; Slingerland, J. B.; more...
    New England Journal of Medicine (2020)

    Fulltext@MSK | Save
  • PD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinoma
    Journal Article

    Migden, M. R.; Rischin, D.; Schmults, C. D.; Guminski, A.; Hauschild, A.; Lewis, K. D.; Chung, C. H.; Hernandez-Aya, L.; Lim, A. M.; Chang, A. L. S.; more...
    New England Journal of Medicine (2018)

    Fulltext@MSK | Save